Additionally, COX-1 may contribute to carcinoma development in the ovary through stimulation of neovascularization and selective inhibition of COX-1, not COX-2, inhibits arachidonic acid-stimulated VEGF production (16–18,36). The gene discussed is VEGFA; the disease is carcinoma.